RSNA and ACR in 2020 established a registry aimed at collecting standardized data on 3D printing performed in healthcare facilities, sharing their insights in a new analysis. 

Despite the great expectations it continues to build, clinical AI is still struggling to find a foothold in healthcare. 

There may be upsides to being less mature at this stage of society’s AI shift—relentless optimism could detract from mitigating potential risks.

The new expert consensus decision pathway replaces a similar document from 2019 and is to be used in conjunction with heart failure guidelines published in 2022 by the ACC, American Heart Association and Heart Failure Society of America.

The Digital Health Advisory Committee is tasked with providing perspective and recommendations on a wide variety of topics. These insights will then help the FDA draft new policies and make other important decisions.

Cardiologist Dan Blumenthal, MD, MBA, explains how changes in Medicare payments will greatly impact cardiology in the years ahead. In just a few short years, the business side of cardiology could look substantially different than it does today. 

Novolink Health, previously known as Duxlink Health, has a decade of experience treating high-risk, high-cost patients from the comfort of their own homes. It will now function as a division within Florida-based Cardiovascular Associates of America.

The Danish pharmaceutical company said it will resubmit its application in 2025 to have Wegovy approved for use in heart failure patients.